Certara, Inc. CERT
NASDAQ · United States · Technology Services
$9.40+0.20 (+2.17%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
AI, cloud and HPC are accelerating virtual screening and precision medicine, expanding adoption across pharma, biotech and CROs in oncology, neurology, rare and infectious diseases.Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "In-Silico Drug Discovery Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global In-Silico Drug Discovery Market to Reach US$6 Billion by 2030 The global in-silico drug discovery market was valued at US$3.3 billion in 2024 and i
AI, machine learning and big data are advancing virtual screening and precision medicine, creating opportunities in molecular modeling, docking and data integration.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Drug Discovery Informatics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Drug Discovery Informatics was estimated at US$4.0 Billion in 2025 and is projected to reach US$8.7 Billion by 2032, growing at a CAGR of 11.9% from 2025
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.